Is TB-500 Legal to Purchase for Research?: Comparison
In vitro research by registered institution with documented protocol Legal under 21 CFR 312 Active IRB/IACUC protocol, supplier CoA, 'research use only' labeling Low. Compliant if documentation maintained This is the safest legal pathway. Peptide purchase alig
This comparison does not assign a generated winner or score.
- In vitro research by registered institution with documented protocol
- Legal under 21 CFR 312
- Active IRB/IACUC protocol, supplier CoA, 'research use only' labeling
- Low. Compliant if documentation maintained
- This is the safest legal pathway. Peptide purchase aligns with federal research exemptions when intent and documentation are clear
- Animal model research with institutional oversight
- Legal under 21 CFR 312 and IACUC standards
- IACUC-approved protocol, veterinary supervision if required, proper waste disposal
- Low to moderate. Depends on protocol adherence
- Legal and common in academic settings. Institutional compliance infrastructure typically handles documentation
- Personal purchase by individual without research affiliation
- Grey zone. Legal to purchase, illegal to use for unapproved human administration
- None enforceable. Buyer intent determines FDA classification risk
- High. FDA considers this unapproved drug distribution if human use is implied
- The peptide itself isn't controlled, but purchasing without a research entity creates documentation gaps that suggest non-compliant intent
- Purchase from supplier making therapeutic claims or providing dosing instructions
- Illegal. Supplier is distributing unapproved drugs
- Supplier must not make disease claims or provide human use guidance
- Very high. Both buyer and seller at risk of FDA enforcement
- Even if your intent is legitimate research, purchasing from a non-compliant supplier creates a paper trail linking your institution to illegal drug distribution
- Importation from international supplier without FDA registration
- Illegal if intended for human use; legal for research if properly documented
- CBP and FDA import compliance, research entity documentation, proper labeling
- Moderate to high. Customs may seize shipments lacking clear research documentation
- International sourcing adds CBP scrutiny. Seizure rates increase significantly if labeling or documentation suggests human use